Brief: Teoxane SA Reports 5.0% Stake In Revance Therapeutics As Of August 22
01/09/2023 17:26
Sept 1 (Reuters) -
* TEOXANE SA REPORTS 5.0% STAKE IN REVANCE THERAPEUTICS AS OF AUGUST 22 - SEC FILING
Source text - https://bityl.co/KqPM
Further company coverage: RVNC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Revance Therapeutics
See all newsBrief: Crown Laboratories and Revance Therapeutics Announce Expiration of Tender Offer
Brief: Crown Laboratories And Revance Amend A&R Merger Agreement
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Kratos, Forward Air, Bank stocks
U.S. STOCKS ON THE MOVE-Henry Schein, natgas firms, Citigroup